Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729948 · ClinicalTrials.gov registry record · NA
Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02729948 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1 participants.
The verdict
NCT02729948, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well tethered capsule endoscope works in screening patients with Barrett esophagus (BE), a condition where the lining of the esophagus has changed or has been replaced with abnormal cells that may lead to cancer also called esophageal cancer. In an attempt to prevent the progression from BE to esophageal cancer, patients undergo a standard procedure called esophagogastroduodenoscopy (EGD) where patients are sedated and the doctor uses an endoscope to examine the tissue in the esophagus. Tethered capsule endoscope is a tiny capsule with a laser scan inside and a very thin cord attached to it. Patients swallow the capsule and the thin cord keeps the capsule in specific area in the esophagus. After pictures of the lining of esophagus are taken, the capsule is removed using the thin cord. Tethered capsule endoscope may be able to identify tissue changes in patients with BE without the need for sedation or anesthesia, thus eliminating the associated risks and costs associated with EGD.
Interventions
- OTHER Survey Administration
- DEVICE Tethered Capsule Endoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-07-28 |
| Est. Completion | 2017-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729948
The ClinicalTrials.gov registry entry for NCT02729948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT02729948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02729948 about?
NCT02729948 is a clinical study titled "Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus". This pilot clinical trial studies how well tethered capsule endoscope works in screening patients with Barrett esophagus (BE), a condition where the lining of the esophagus has changed or has been replaced with abnormal cells that may lead to cancer also called esophageal cancer. In an attempt to pr...
What is the current status of trial NCT02729948?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2016-07-28. Estimated completion is 2017-08-03.
What interventions are being tested in trial NCT02729948?
The interventions under investigation include: Survey Administration (OTHER), Tethered Capsule Endoscope (DEVICE).
Who is sponsoring clinical trial NCT02729948?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.